Interleukin-1 beta: A potential link between stress and the development of visceral obesity

BMC Physiology

Volumn 12, Issue 1, 2012, Pages

  Speaker, Kristin J ^a   Fleshner, Monika ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA;

ABDOMINAL OBESITY; ADIPOSE TISSUE; ANIMAL; BODY FAT DISTRIBUTION; HUMAN; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; RAT; REVIEW; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ANIMALS; BODY FAT DISTRIBUTION; CYTOKINES; HUMANS; INTERLEUKIN-1BETA; OBESITY, ABDOMINAL; RATS; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 84862736086     PISSN: None     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-12-8     Document Type: Review

References (162)

1. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, et al. Lancet 2005 366 1640 1649
2. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Canoy D, Boekholdt SM, Wareham N, Luben R, Welch A, Bingham S, Buchan I, Day N, Khaw KT, Circulation 2007 116 2933 2943
3. Serum lipid concentration in relation to anthropometric indices of central and peripheral fat distribution in 20,021 British men and women: results from the EPIC-Norfolk population-based cohort study. Canoy D, Wareham N, Luben R, Welch A, Bingham S, Day N, Khaw KT, Atherosclerosis 2006 189 420 427
4. Abdominal fat distribution and disease: an overview of epidemiological data. Bjorntorp P, Ann Med 1992 24 15 18
5. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA, Nat Rev Immunol 2011 11 607 615
6. Hormonal regulation of visceral adipose tissue. Bjorntorp P, Growth Horm IGF Res 1998 8 Suppl B 15 17
7. The regulation of adipose tissue distribution in humans. Bjorntorp P, Int J Obes Relat Metab Disord 1996 20 291 302
8. Do stress reactions cause abdominal obesity and comorbidities? Bjorntorp P, Obes Rev 2001 2 73 86
9. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. Rosmond R, Dallman MF, Bjorntorp P, J Clin Endocrinol Metab 1998 83 1853 1859
10. Stress, visceral obesity, and metabolic complications. Kyrou I, Chrousos GP, Tsigos C, Ann N Y Acad Sci 2006 1083 77 110
11. Glucocorticoid hormone binding to human adipose tissue. Rebuffe-Scrive M, Lundholm K, Bjorntorp P, Eur J Clin Invest 1985 15 267 271
12. A transgenic model of visceral obesity and the metabolic syndrome. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS, Science 2001 294 2166 2170
13. Immunometabolism: an emerging frontier. Mathis D, Shoelson SE, Nat Rev Immunol 2011 11 81
14. Investigation of complex stressor exposure on metabolic and inflammatory proteins in plasma and white adipose tissue. Speaker KJ SA, Herrera J, Cox S, Strong P, Greenwood B, Fleshner M, Brain, Behavior and Immmunity 2011 25 233 S234
15. Prevalence and trends in obesity among US adults, 1999-2008. Flegal KM, Carroll MD, Ogden CL, Curtin LR, JAMA 2010 303 235 241
16. Insulin-sensitive obesity. Kloting N, Fasshauer M, Dietrich A, Kovacs P, Schon MR, Kern M, Stumvoll M, Bluher M, Am J Physiol Endocrinol Metab 2010 299 506 E515
17. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ, Diabetes 1996 45 633 638
18. Metabolic and body composition factors in subgroups of obesity: what do we know? Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET, J Clin Endocrinol Metab 2004 89 2569 2575
19. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G, J Clin Invest 1997 100 1166 1173
20. Body fat distribution, insulin resistance, and metabolic diseases. Bjorntorp P, Nutrition 1997 13 795 803
21. Preventing diabetes-applying pathophysiological and epidemiological evidence. Fujimoto WY, Bergstrom RW, Boyko EJ, Chen KW, Kahn SE, Leonetti DL, McNeely MJ, Newell LL, Shofer JB, Tsunehara CH, Wahl PW, Br J Nutr 2000 84 Suppl 2 173 S176
22. The concurrent accumulation of intraabdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, Wang F, Hull RL, Boyko EJ, Retzlaff BM, et al. Diabetes 2002 51 1005 1015
23. A pilot study of long- term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Thorne A, Lonnqvist F, Apelman J, Hellers G, Arner P, Int J Obes Relat Metab Disord 2002 26 193 199
24. Abdominal obesity and metabolic syndrome. Despres JP, Lemieux I, Nature 2006 444 881 887
25. Regional adiposity and morbidity. Kissebah AH, Krakower GR, Physiol Rev 1994 74 761 811
26. Gluteofemoral body fat as a determinant of metabolic health. Manolopoulos KN, Karpe F, Frayn KN, Int J Obes (Lond) 2010 34 949 959
27. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Tanko LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C, Circulation 2003 107 1626 1631
28. Thrifty genes and human obesity. Are we chasing ghosts? Bjorntorp P, Lancet 2001 358 1006 1008
29. Heterogeneity in adipose tissue metabolism: causes, implications and management of regional adiposity. Abate N, Garg A, Prog Lipid Res 1995 34 53 70
30. What are subcutaneous adipocytes really good for? Klein J, Permana PA, Owecki M, Chaldakov GN, Bohm M, Hausman G, Lapiere CM, Atanassova P, Sowinski J, Fasshauer M, et al. Exp Dermatol 2007 16 45 70
31. Obesity as a medical problem. Kopelman PG, Nature 2000 404 635 643
32. Associations between gender, age and waist circumference. Stevens J, Katz EG, Huxley RR, Eur J Clin Nutr 2010 64 6 15
33. Age-related changes in total and regional fat distribution. Kuk JL, Saunders TJ, Davidson LE, Ross R, Ageing Res Rev 2009 8 339 348
34. Cardiorespiratory fitness is associated with lower abdominal fat independent of body mass index. Wong SL, Katzmarzyk P, Nichaman MZ, Church TS, Blair SN, Ross R, Med Sci Sports Exerc 2004 36 286 291
35. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, Janssen I, Ann Intern Med 2000 133 92 103
36. Effect of dietary fat content on total and regional adiposity in men and women. George V, Tremblay A, Despres JP, Leblanc C, Bouchard C, Int J Obes 1990 14 1085 1094
37. Fructose consumption: considerations for future research on its effects on adipose distribution, lipid metabolism, and insulin sensitivity in humans. Stanhope KL, Havel PJ, J Nutr 2009 139 1236S 1241S
38. Role of Fructose-Containing Sugars in the Epidemics of Obesity and Metabolic Syndrome. Stanhope KL, Annu Rev Med 2012 63 329 343
39. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Chiolero A, Faeh D, Paccaud F, Cornuz J, Am J Clin Nutr 2008 87 801 809
40. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G, Br Med J (Clin Res Ed) 1984 288 1401 1404
41. Aetiology of obesity: a striving after wind? Rosmond R, Obes Rev 2004 5 177 181
42. Psychosocial and socio-economic factors in women and their relationship to obesity and regional body fat distribution. Rosmond R, Bjorntorp P, Int J Obes Relat Metab Disord 1999 23 138 145
43. Comparative analysis of highly defined proteases for the isolation of adipose tissue-derived stem cells. Pilgaard L, Lund P, Rasmussen JG, Fink T, Zachar V, Regen Med 2008 3 705 715
44. Role of the medial prefrontal cortex in coping and resilience. Maier SF, Watkins LR, Brain Res 2010 1355 52 60
45. Chronic stress and obesity: a new view of "comfort food". Dallman MF, Pecoraro N, Akana SF, La Fleur SE, Gomez F, Houshyar H, Bell ME, Bhatnagar S, Laugero KD, Manalo S, Proc Natl Acad Sci U S A 2003 100 11696 11701
46. Smoking clinic failures and recent life stress. Gunn RC, Addict Behav 1983 8 83 87
47. Stress and alcohol use: moderating effects of gender, coping, and alcohol expectancies. Cooper ML, Russell M, Skinner JB, Frone MR, Mudar P, J Abnorm Psychol 1992 101 139 152
48. The role of stress in alcohol use, alcoholism treatment, and relapse. Brady KT, Sonne SC, Alcohol Res Health 1999 23 263 271
49. Can stress cause depression? van Praag HM, World J Biol Psychiatry 2005 6 Suppl 2 5 22
50. Overweight is risking fate. Bjorntorp PA, Best Practice & Research Clinical Endocrinology & Metabolism 1999 13 47 69
51. Contribution of stress to the development of the metabolic syndrome. In memory of Per Bjorntorp (1931-2003). Rosmond R, Lakartidningen 2004 101 1371 1375
52. Stressors and mood measured on a momentary basis are associated with salivary cortisol secretion. Smyth J, Ockenfels MC, Porter L, Kirschbaum C, Hellhammer DH, Stone AA, Psychoneuroendocrinology 1998 23 353 370
53. Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus. Bjorntorp P, Holm G, Rosmond R, Diabet Med 1999 16 373 383
54. Neuroendocrine disorders cause stress- related disease. "Civilization syndrome" is a growing health problem. Bjorntorp P, Holm G, Rosmond R, Lakartidningen 1999 96 893 896
55. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL, JAMA 1994 272 205 211
56. Assessing the economic impact of stress-the modern day hidden epidemic. Kalia M, Metabolism 2002 51 49 53
57. A "family-based" approach to the treatment of obese type II diabetic patients. Wing RR, Marcus MD, Epstein LH, Jawad A, J Consult Clin Psychol 1991 59 156 162
58. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Wajchenberg BL, Endocr Rev 2000 21 697 738
59. When the social self is threatened: shame, physiology, and health. Dickerson SS, Gruenewald TL, Kemeny ME, J Pers 2004 72 1191 1216
60. Stress, eating and the reward system. Adam TC, Epel ES, Physiol Behav 2007 91 449 458
61. Poverty and obesity: the role of energy density and energy costs. Drewnowski A, Specter SE, Am J Clin Nutr 2004 79 6 16
62. Chronic social stress, hedonism and vulnerability to obesity: lessons from rodents. Coccurello R, D'Amato FR, Moles A, Neurosci Biobehav Rev 2009 33 537 550
63. Social stress: from rodents to primates. Tamashiro KL, Nguyen MM, Sakai RR, Front Neuroendocrinol 2005 26 27 40
64. Inhibition of the central extended amygdala by loud noise and restraint stress. Day HE, Nebel S, Sasse S, Campeau S, Eur J Neurosci 2005 21 441 454
65. Physiological Consequences of Repeated Exposures to Conditioned Fear. Thompson RS, Strong PV, Fleshner M, Behavior Sciences 2012 2 2 57 78
66. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Johnson JD, Campisi J, Sharkey CM, Kennedy SL, Nickerson M, Greenwood BN, Fleshner M, Neuroscience 2005 135 1295 1307
67. Changes in lipoprotein lipase modulate tissue energy supply during stress. Ricart-Jane D, Cejudo-Martin P, Peinado-Onsurbe J, Lopez-Tejero MD, Llobera M, J Appl Physiol 2005 99 1343 1351
68. Chronic stress, energy balance and adiposity in female rats. Solomon MB, Jankord R, Flak JN, Herman JP, Solomon MB, Jankord R, Flak JN, Herman JP, Physiol Behav 2010 102 84 90
69. Are stress eaters at risk for the metabolic syndrome? Epel E, Jimenez S, Brownell K, Stroud L, Stoney C, Niaura R, Ann N Y Acad Sci 2004 1032 208 210
70. Dynamic body weight and body composition changes in response to subordination stress. Tamashiro KL, Hegeman MA, Nguyen MM, Melhorn SJ, Ma LY, Woods SC, Sakai RR, Physiol Behav 2007 91 440 448
71. Social stress and recovery: implications for body weight and body composition. Tamashiro KL, Nguyen MM, Ostrander MM, Gardner SR, Ma LY, Woods SC, Sakai RR, Am J Physiol Regul Integr Comp Physiol 2007 293 1864 R1874
72. Effects of exercise and stress on body fat distribution in male cynomolgus monkeys. Jayo JM, Shively CA, Kaplan JR, Manuck SB, Int J Obes Relat Metab Disord 1993 17 597 604
73. Regional obesity and coronary artery atherosclerosis in females: a non-human primate model. Shively CA, Clarkson TB, Acta Med Scand Suppl 1988 723 71 78
74. Social status and coronary artery atherosclerosis in female monkeys. Shively CA, Clarkson TB, Arterioscler Thromb 1994 14 721 726
75. Catecholaminergic innervation of white adipose tissue in Siberian hamsters. Youngstrom TG, Bartness TJ, Am J Physiol 1995 268 744 R751
76. Neuroregulation of adipose tissue: molecular and hormonal mechanisms. Rebuffe-Scrive M, Int J Obes 1991 15 Suppl 2 83 86
77. Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Bartness TJ, Bamshad M, Am J Physiol 1998 275 1399 R1411
78. Characterization and comparison of adipose tissue-derived cells from human subcutaneous and omental adipose tissues. Toyoda M, Matsubara Y, Lin K, Sugimachi K, Furue M, Cell Biochem Funct 2009 27 440 447
79. Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Tchkonia T, Tchoukalova YD, Giorgadze N, Pirtskhalava T, Karagiannides I, Forse RA, Koo A, Stevenson M, Chinnappan D, Cartwright A, et al. Am J Physiol Endocrinol Metab 2005 288 267 E277
80. Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. Altintas MM, Azad A, Nayer B, Contreras G, Zaias J, Faul C, Reiser J, Nayer A, J Lipid Res 2011 52 480 488
81. Fat depotspecific characteristics are retained in strains derived from single human preadipocytes. Tchkonia T, Giorgadze N, Pirtskhalava T, Thomou T, DePonte M, Koo A, Forse RA, Chinnappan D, Martin-Ruiz C, von Zglinicki T, Kirkland JL, Diabetes 2006 55 2571 2578
82. Depot-specific differences in adipogenic progenitor abundance and proliferative response to high-fat diet. Joe AW, Yi L, Even Y, Vogl AW, Rossi FM, Stem Cells 2009 27 2563 2570
83. Secretome analysis of rat adipose tissues shows location-specific roles for each depot type. Roca-Rivada A, Alonso J, Al-Massadi O, Castelao C, Peinado JR, Seoane LM, Casanueva FF, Pardo M, J Proteomics 2011 74 1068 1079
84. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Bjorntorp P, Arteriosclerosis 1990 10 493 496
85. Critical role of the mesenteric depot versus other intra-abdominal adipose depots in the development of insulin resistance in young rats. Catalano KJ, Stefanovski D, Bergman RN, Diabetes 2010 59 1416 1423
86. Visceral fat and insulin resistance-causative or correlative? Frayn KN, Br J Nutr 2000 83 Suppl 1 71 S77
87. Role stress on obesity and energy balance. Khnychenko LK, Sapronov NS, Usp Fiziol Nauk 2010 41 64 71
88. Hypothalamic inflammation and obesity. Araujo EP, Torsoni MA, Velloso LA, Vitam Horm 2010 82 129 143
89. The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Balistreri CR, Caruso C, Candore G, Mediators Inflamm 2010 2010 802078
90. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. Rebuffe-Scrive M, Krotkiewski M, Elfverson J, Bjorntorp P, J Clin Endocrinol Metab 1988 67 1122 1128
91. Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions. Stanhope KL, Griffen SC, Bremer AA, Vink RG, Schaefer EJ, Nakajima K, Schwarz JM, Beysen C, Berglund L, Keim NL, Havel PJ, Am J Clin Nutr 2011 94 112 119
92. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. Fried SK, Russell CD, Grauso NL, Brolin RE, J Clin Invest 1993 92 2191 2198
93. Qualitative regional differences in adipose tissue growth and cellularity in male Wistar rats fed ad libitum. DiGirolamo M, Fine JB, Tagra K, Rossmanith R, Am J Physiol 1998 274 1460 R1467
94. Differential responses of visceral and subcutaneous fat depots to nutrients. Einstein FH, Atzmon G, Yang XM, Ma XH, Rincon M, Rudin E, Muzumdar R, Barzilai N, Diabetes 2005 54 672 678
95. The stromal-vascular fraction of adipose tissue contributes to major differences between subcutaneous and visceral fat depots. Peinado JR, Jimenez-Gomez Y, Pulido MR, Ortega-Bellido M, Diaz-Lopez C, Padillo FJ, Lopez-Miranda J, Vazquez-Martinez R, Malagon MM, Proteomics 2010 10 3356 3366
96. LMNA mRNA expression is altered in human obesity and type 2 diabetes. Miranda M, Chacon MR, Gutierrez C, Vilarrasa N, Gomez JM, Caubet E, Megiam A, Vendrell J, Obesity (Silver Spring) 2008 16 1742 1748
97. Diet-induced adipocyte number increase in adult rats: a new model of obesity. Faust IM, Johnson PR, Stern JS, Hirsch J, Am J Physiol 1978 235 279 E286
98. Adipocyte differentiation and gene expression. Ntambi JM, Young-Cheul K, J Nutr 2000 130 3122S 3126S
99. Adipose tissue lymphocytes: types and roles. Caspar-Bauguil S, Cousin B, Bour S, Castiella L, Penicaud L, Carpene C, J Physiol Biochem 2009 65 423 436
100. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Permana PA, Menge C, Reaven PD, Biochem Biophys Res Commun 2006 341 507 514
101. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids andtumor necrosis factor alpha. Suganami T, Nishida J, Ogawa Y, Arterioscler Thromb Vasc Biol 2005 25 2062 2068
102. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Besedovsky H, del Rey A, Sorkin E, Dinarello CA, Science 1986 233 652 654
103. Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes. Kopp A, Buechler C, Neumeier M, Weigert J, Aslanidis C, Scholmerich J, Schaffler A, Obesity (Silver Spring) 2009 17 648 656
104. Adipose tissue: a regulator of inflammation. Juge-Aubry CE, Henrichot E, Meier CA, Best Pract Res Clin Endocrinol Metab 2005 19 547 566
105. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Black PH, Med Hypotheses 2006 67 879 891
106. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Steptoe A, Hamer M, Chida Y, Brain Behav Immun 2007 21 901 912
107. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Segerstrom SC, Miller GE, Psychol Bull 2004 130 601 630
108. Exercise and the immune system: regulation, integration, and adaptation. Pedersen BK, Hoffman-Goetz L, Physiol Rev 2000 80 1055 1081
109. Elevated IL-1beta contributes to antibody suppression produced by stress. Moraska A, Campisi J, Nguyen KT, Maier SF, Watkins LR, Fleshner M, J Appl Physiol 2002 93 207 215
110. Pro-inflammatory cytokines and adipose tissue. Coppack SW, Proc Nutr Soc 2001 60 349 356
111. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. Rubartelli A, Cozzolino F, Talio M, Sitia R, EMBO J 1990 9 1503 1510
112. Mechanisms of interleukin-1beta release. Eder C, Immunobiology 2009 214 543 553
113. The inflammasome: a danger sensing complex triggering innate immunity. Petrilli V, Dostert C, Muruve DA, Tschopp J, Curr Opin Immunol 2007 19 615 622
114. Sensing pathogens and danger signals by the inflammasome. Pedra JH, Cassel SL, Sutterwala FS, Curr Opin Immunol 2009 21 10 16
115. The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. Singer II, Scott S, Chin J, Bayne EK, Limjuco G, Weidner J, Miller DK, Chapman K, Kostura MJ, J Exp Med 1995 182 1447 1459
116. Dynamic regulation of the proinflammatory cytokine, interleukin-1beta: molecular biology for non-molecular biologists. Watkins LR, Hansen MK, Nguyen KT, Lee JE, Maier SF, Life Sci 1999 65 449 481
117. ELISA kits based on monoclonal antibodies do not measure total IL-1 beta synthesis. Dinarello CA, J Immunol Methods 1992 148 255 259
118. Stress-induced hemoconcentration of blood cells and lipids in healthy women during acute psychological stress. Patterson SM, Matthews KA, Allen MT, Owens JF, Health Psychol 1995 14 319 324
119. Endocrine functions of adipose tissue. Waki H, Tontonoz P, Annu Rev Pathol 2007 2 31 56
120. Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Doerrler W, Feingold KR, Grunfeld C, Cytokine 1994 6 478 484
121. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Lagathu C, Yvan-Charvet L, Bastard JP, Maachi M, Quignard-Boulange A, Capeau J, Caron M, Diabetologia 2006 49 2162 2173
122. Cytokines stimulate lipolysis and decrease lipoprotein lipase activity in cultured fat cells by a prostaglandin independent mechanism. Hardardottir I, Doerrler W, Feingold KR, Grunfeld C, Biochem Biophys Res Commun 1992 186 237 243
123. LPS and proinflammatory cytokines decrease lipin-1 in mouse adipose tissue and 3T3-L1 adipocytes. Lu B, Lu Y, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR, Am J Physiol Endocrinol Metab 2008 295 1502 E1509
124. Regulation of fat specific protein 27 by isoproterenol and TNF- alpha to control lipolysis in murine adipocytes. Ranjit S, Boutet E, Gandhi P, Prot M, Tamori Y, Chawla A, Greenberg AS, Puri V, Czech MP, J Lipid Res 2011 52 221 236
125. Regulation of lipoprotein lipase synthesis and 3T3-L1 adipocyte metabolism by recombinant interleukin 1. Price SR, Mizel SB, Pekala PH, Biochim BiophysActa 1986 889 374 381
126. Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. Feingold KR, Doerrler W, Dinarello CA, Fiers W, Grunfeld C, Endocrinology 1992 130 10 16
127. Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Bruun JM, Pedersen SB, Kristensen K, Richelsen B, Mol Cell Endocrinol 2002 190 91 99
128. Leptin upregulates beta3-integrin expression and interleukin-1beta, upregulates leptin and leptin receptor expression in human endometrial epithelial cell cultures. Gonzalez RR, Leavis P, Endocrine 2001 16 21 28
129. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. Muller G, Ertl J, Gerl M, Preibisch G, J Biol Chem 1997 272 10585 10593
130. Leptin: fundamental aspects. Trayhurn P, Hoggard N, Mercer JG, Rayner DV, Int J Obes Relat Metab Disord 1999 23 Suppl 1 22 28
131. Modulation of 11 beta-hydroxysteroid dehydrogenase type 1 in mature human subcutaneous adipocytes by hypothalamic messengers. Friedberg M, Zoumakis E, Hiroi N, Bader T, Chrousos GP, Hochberg Z, J Clin Endocrinol Metab 2003 88 385 393
132. Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M, Stewart PM, Endocrinology 2001 142 1982 1989
133. Characterization of regional and gender differences in glucocorticoid receptors and lipoprotein lipase activity in human adipose tissue. Pedersen SB, Jonler M, Richelsen B, J Clin Endocrinol Metab 1994 78 1354 1359
134. Effects of cortisol and growthhormone on lipolysis in human adipose tissue. Ottosson M, Lonnroth P, Bjorntorp P, Eden S, J Clin Endocrinol Metab 2000 85 799 803
135. Disengaging insulin from corticosterone: roles of each on energy intake and disposition. Warne JP, Akana SF, Ginsberg AB, Horneman HF, Pecoraro NC, Dallman MF, Am J Physiol Regul Integr Comp Physiol 2009 296 1366 R1375
136. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Fernandez-Real JM, Ricart W, Diabetologia 1999 42 1367 1374
137. Toward quantifying the usage costs of human immunity: Altered metabolic rates and hormone levels during acute immune activation in men. Muehlenbein MP, Hirschtick JL, Bonner JZ, Swartz AM, Am J Hum Biol 2010 22 546 556
138. Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Im SS, Yousef L, Blaschitz C, Liu JZ, Edwards RA, Young SG, Raffatellu M, Osborne TF, Cell metabolism 2011 13 540 549
139. Obesity, inflammation, and cardiovascular risk. Mathieu P, Lemieux I, Despres JP, Clin Pharmacol Ther 2010 87 407 416
140. Role of body fat distribution and the metabolic complications of obesity. Jensen MD, J Clin Endocrinol Metab 2008 93 57 S63
141. Impaired insulin action in subcutaneous adipocytes from women with visceral obesity. Johnson JA, Fried SK, Pi-Sunyer FX, Albu JB, Am J Physiol Endocrinol Metab 2001 280 4049
142. Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosisfactor-alpha, and inflammation. Isakson P, Hammarstedt A, Gustafson B, Smith U, Diabetes 2009 58 1550 1557
143. Sucrose intake and corticosterone interact with cold to modulate ingestive behaviour, energy balance, autonomic outflow and neuroendocrine responses during chronic stress. Bell ME, Bhargava A, Soriano L, Laugero K, Akana SF, Dallman MF, J Neuroendocrinol 2002 14 330 342
144. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. Eckel RH, N Engl J Med 1989 320 1060 1068
145. Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. Beutler BA, Cerami A, J Immunol 1985 135 3969 3971
146. The role of TNF-alpha in human adipose tissue: prevention of weight gain at the expense of insulin resistance? Hube F, Hauner H, Horm Metab Res 1999 31 626 631
147. Interleukin-1beta-induced insulin resistance in adipocytes through downregulation of insulin receptor substrate-1 expression. Jager J, Gremeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF, Endocrinology 2007 148 241 251
148. Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique. Sadur CN, Eckel RH, J Clin Invest 1982 69 1119 1125
149. IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. Matsuki T, Horai R, Sudo K, Iwakura Y, J Exp Med 2003 198 877 888
150. Lipid droplets: size matters. Suzuki M, Shinohara Y, Ohsaki Y, Fujimoto T, J Electron Microsc (Tokyo) 2011 60 Suppl 1 101 S116
151. Regional differences in adipose tissue metabolism in obese men. Boivin A, Brochu G, Marceau S, Marceau P, Hould FS, Tchernof A, Metabolism 2007 56 533 540
152. Identification ofdepot-specific human fat cell progenitors through distinct expression profilesand developmental gene patterns. Tchkonia T, Lenburg M, Thomou T, Giorgadze N, Frampton G, Pirtskhalava T, Cartwright A, Cartwright M, Flanagan J, Karagiannides I, et al. Am J Physiol Endocrinol Metab 2007 292 298 E307
153. Qualitative regional differences in adipose tissue growth and cellularity in male Wistar rats fed ad libitum. DiGirolamo M, Fine JB, Tagra K, Rossmanith R, Am J Physiol Regul Integr Comp Physiol 1998 274 1460 R1467
154. A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation. Lu C, Kumar PA, Fan Y, Sperling MA, Menon RK, Endocrinology 2010 151 2189 2199
155. The integration of lipid-sensing and anti-inflammatory effects: how the PPARs play a role in metabolic balance. Nunn AV, Bell J, Barter P, Nucl Recept 2007 5 1
156. Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade. Suzawa M, Takada I, Yanagisawa J, Ohtake F, Ogawa S, Yamauchi T, Kadowaki T, Takeuchi Y, Shibuya H, Gotoh Y, et al. Nat Cell Biol 2003 5 224 230
157. Stromelysin-1 regulates adipogenesis during mammary gland involution. Alexander CM, Selvarajan S, Mudgett J, Werb Z, J Cell Biol 2001 152 693 703
158. Tissue inhibitor of metalloproteinase-1 predicts adiposity in humans. Kralisch S, Bluher M, Tonjes A, Lossner U, Paschke R, Stumvoll M, Fasshauer M, Eur J Endocrinol 2007 156 257 261
159. Tissue inhibitor of metalloproteinase-1 mRNA production and protein secretion are induced by interleukin-1 beta in 3T3-L1 adipocytes. Weise S, Kralisch S, Sommer G, Lossner U, Bluher M, Stumvoll M, Fasshauer M, J Endocrinol 2008 198 169 174
160. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. Student AK, Hsu RY, Lane MD, J Biol Chem 1980 255 4745 4750
161. Chronic stress and comfort foods: self- medication and abdominal obesity. Dallman MF, Pecoraro NC, la Fleur SE, Brain Behav Immun 2005 19 275 280
162. Expanding the definition of hypothalamic obesity. Hochberg I, Hochberg Z, Obes Rev 2010 11 709 721